Medline Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Medline Inc in the second quarter 2026?
Medline Inc achieved a return on average equity (ROE) of 4.5 % in its second quarter 2026, this is above MDLN's average return on equity of 0%.
Medline Inc s equity during the 12 months ending in the second quarter 2026 are valued at $18 billion

ROE decreased relative to the period ending , due to the decline in net income.

Within the Medical Equipment & Supplies industry Medline Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the first quarter 2026 at no. .

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Jun 28 2025) II. Quarter	(Mar 29 2025) I. Quarter
Y / Y Equity Change	-	-	-	-	-
Y / Y Net Income Change	-99.17 %	-	-	-	-
Net Income (TTM) in Millions	836	17,506	17,138	17,138	16,809
Return On Equity (TTM)	4.5 %	126.95 %	191.43 %	414.86 %	-
MDLN's Total Ranking	#	#	#	#	#
Equity (TTM) in Millions	19,077	19,349	19,286	16,524	0
Seq. Equity Change	-1.41 %	0.33 %	16.72 %	-	-
Seq. Net Income Change	-62.23 %	-	-	-98.04 %	-

Back to MDLN Management Effectiveness >> MDLN's 5 Years Annual ROE >> Compare MDLN ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Equity Statistics
High	Average	Low
0 %	0 %	0 %

MDLN Annual Return On Equity	(Dec 31 2025) 2025
Total Equity in Millions	19,286	0	0	0	0
Y / Y Equity Change	-	-	-	-	-
Net Income in Millions	1,161	0	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	6.02 %	-	-	-	-

Back to MDLN Management Effectiveness >> MDLN's 5 Years Annual ROE >> Compare MDLN ROE to its Competitors

Annual Roe Comment

In 2025 ROE fell to 6.02 %, despite net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
MDLN's' Return on Equity at Yahoo Finance
MDLN's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for MDLN's Competitors
Subscribers only: Roe for Medline Inc 's Suppliers
Subscribers only: Return On Equity for MDLN's Customers

Companies with similar Return On Equity at Jun 27 2026, within Healthcare Sector	ROE
Protagonist Therapeutics inc	11.80 %
Entrada Therapeutics Inc	11.77 %
Haemonetics Corporation	11.66 %
Globus Medical Inc	11.59 %
Labcorp Holdings Inc	11.58 %
Tactile Systems Technology Inc	11.49 %
Nature s Sunshine Products inc	11.26 %
Penumbra Inc	11.09 %
Henry Schein Inc	10.88 %
Cadre Holdings inc	10.76 %
Medtronic Plc	10.64 %
Viemed Healthcare Inc	10.53 %
U S Physical Therapy Inc	10.50 %
The Pennant Group Inc	10.18 %
Amphastar Pharmaceuticals Inc	10.11 %
Align Technology inc	10.09 %
Ardent Health Inc	9.92 %
Edwards Lifesciences Corporation	9.65 %
Addus Homecare Corp	9.57 %
IMPACT BIOMEDICAL INC.	9.56 %
Teva Pharmaceutical Industries Limited	9.11 %
Merit Medical Systems Inc	9.07 %
Bio techne Corp	9.01 %
Utah Medical Products Inc	8.74 %
Vaso Corporation	8.65 %
Veracyte Inc	8.64 %
Corcept Therapeutics Inc	8.27 %
Integer Holdings Corporation	7.43 %
Pacific Health Care Organization Inc	7.42 %
Vericel Corporation	6.91 %

Date modified: 2026-09-08T15:11:45+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.